By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – German biotech firm MorphoSys today announced it has acquired Sloning BioTechnology, which is developing new methods of synthetic biology, for €19 million ($26.5 million).
Registering provides access to this and other free content.
Already have an account?Login Now.
The Australian High Court rules that isolated genetic material cannot be patented.
The startup incubator Y Combinator is launching a nonprofit research lab.
In Nature this week: genomic analysis of 200 bird species, and more.
In Genome Research this week: vervet genome, tandem repeats affect gene expression in great apes, and more.